Skip to main content

The successful grantee will support the development of the revised RBM AIM document, through a broad consultative process, resulting in its approval by the RBM Board in May 2021.  

This will include:

1.    Review of the current AIM document, identifying its strengths and areas for improvement, as well as opportunities to update information  “Action and Investment to Defeat Malaria 2016-2030”

2.    Consultations (as needed) with the WHO team leading the GTS revision, review of proposed GTS updates, and their implications for a revised AIM.

3.    Targeted consultations with health and malaria financing experts (including from WHO, World Bank, Global Fund, NGOs working on health financing with malaria-endemic countries, and academics) through various methods (one-on-one, focus groups, survey, etc.) to develop a high-level investment case for external malaria financing, and a domestic malaria financing strategy that promotes best practices in public financial management, public health insurance, private provider contracting, the development of national End Malaria Funds, and the integrated delivery of community health
prevention, diagnosis, and treatment services.

4.    Additional consultations through the RBM partner committees (Advocacy and Resource Mobilisation; Country and Regional Support; and Strategic Communications) to ensure that financing recommendations are aligned with technical recommendations to malaria-endemic countries and consensus messaging for the global malaria community. 

5.    Preparation of a draft AIM document for the RBM Board meeting in May 2021 and a final draft thereafter in response to board feedback. A presentation to the Board may also be requested.

The main document can be found here.